DR. LAL PATHLABS LIMITEDDR. LAL PATHLABS LIMITEDDR. LAL PATHLABS LIMITED

DR. LAL PATHLABS LIMITED

No trades
See on Supercharts
Market capitalization
‪187.60 B‬INR
‪2.39 B‬INR
‪20.17 B‬INR
‪36.29 M‬
Beta (1Y)
0.96

About DR. LAL PATHLABS LIMITED

CEO
Bharath Uppiliappan
Headquarters
Gurgaon
Employees (FY)
‪4.05 K‬
Founded
1949
ISIN
INE600L01024
FIGI
BBG009WQGFB4
Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. It also involves in providing diagnostic and healthcare tests and services. The company was founded by S. K. Lal in 1949 and is headquartered in Gurgaon, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LALPATHLAB is 2331.00 INR — it has increased by 3.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange DR. LAL PATHLABS LIMITED stocks are traded under the ticker LALPATHLAB.
DR. LAL PATHLABS LIMITED is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
LALPATHLAB stock is 4.34% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is DR. LAL PATHLABS LIMITED there?
LALPATHLAB earnings for the last quarter are 13.10 INR per share, whereas the estimation was 10.93 INR resulting in a 19.82% surprise. The estimated earnings for the next quarter are 10.11 INR per share. See more details about DR. LAL PATHLABS LIMITED earnings.
DR. LAL PATHLABS LIMITED revenue for the last quarter amounts to ‪6.01 B‬ INR despite the estimated figure of ‪5.89 B‬ INR. In the next quarter revenue is expected to reach ‪5.59 B‬ INR.
Yes, you can track DR. LAL PATHLABS LIMITED financials in yearly and quarterly reports right on TradingView.
LALPATHLAB stock has risen by 0.74% compared to the previous week, the month change is a 11.00% rise, over the last year DR. LAL PATHLABS LIMITED has showed a 22.68% increase.
LALPATHLAB net income for the last quarter is ‪813.00 M‬ INR, while the quarter before that showed ‪1.09 B‬ INR of net income which accounts for −25.62% change. Track more DR. LAL PATHLABS LIMITED financial stats to get the full picture.
Today DR. LAL PATHLABS LIMITED has the market capitalization of ‪186.39 B‬, it has decreased by 2.53% over the last week.
DR. LAL PATHLABS LIMITED dividend yield was 0.66% in 2022, and payout ratio reached 41.63%. The year before the numbers were 0.46% and 28.78% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, LALPATHLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. LAL PATHLABS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
LALPATHLAB reached its all-time high on Sep 15, 2021 with the price of 4243.00 INR, and its all-time low was 696.50 INR and was reached on Jan 20, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪4.05 K‬ employees. See our rating of the largest employees — is DR. LAL PATHLABS LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. LAL PATHLABS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. LAL PATHLABS LIMITED stock shows the neutral signal. See more of DR. LAL PATHLABS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DR. LAL PATHLABS LIMITED future price: according to them, LALPATHLAB price has a max estimate of 2900.00 INR and a min estimate of 1670.00 INR. Read a more detailed DR. LAL PATHLABS LIMITED forecast: see what analysts think of DR. LAL PATHLABS LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. LAL PATHLABS LIMITED EBITDA is ‪5.80 B‬ INR, and current EBITDA margin is 24.71%. See more stats in DR. LAL PATHLABS LIMITED financial statements.